← Leaderboards
Anna M Wu
Beckman Research Institute/City Of Hope
$10,747,779
Attributed
$13,291,345
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,291,345 · 15
By mechanism
R01$6,001,743 · 2
P50$2,487,912 · 3
U54$2,208,253 · 1
R21$1,581,618 · 4
P30$855,322 · 4
P01$156,497 · 1
Top collaborators
- Robert E Reiter8 shared
- Dorthe Schaue2 shared
- Kirstin Anja Zettlitz2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsImagePositron-Emission TomographyMonitorLabelBaseDetectionAntibodiesRadiolabeledMouse ModelResponseTumorMolecularIn VivoBiologicalEvaluationTracerMolecular ImagingEngineeringClinicAntibody EngineeringLaboratoriesResearch PersonnelMalignant Neoplasm Of Prostate
Grant awards (60)
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer$600,896
R01 · FY2025 · CA · contact PI
Small Animal Studies$43,864
P30 · FY2025 · CA · contact PI
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer$685,408
R01 · FY2024 · CA · contact PI
Small Animal Studies$57,159
P30 · FY2024 · CA · contact PI
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer$714,893
R01 · FY2023 · CA · contact PI
Small Animal Studies$54,619
P30 · FY2023 · CA · contact PI
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer$729,981
R01 · FY2022 · CA · contact PI
Small Animal Studies Core$62,650
P30 · FY2022 · CA · contact PI
Small Animal Studies Core$62,650
P30 · FY2021 · CA · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$358,858
R01 · FY2020 · CA · contact PI
Visualizing radiation-induced tumor immune responses$217,100
R21 · FY2020 · CA · contact PI
Small Animal Studies Core$69,794
P30 · FY2020 · CA · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$348,092
R01 · FY2019 · CA · contact PI
Visualizing radiation-induced tumor immune responses$199,166
R21 · FY2019 · CA · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$377,890
R01 · FY2018 · CA · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$444,176
R01 · FY2017 · CA · contact PI
Imaging Core$191,032
P50 · FY2017 · CA · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$444,176
R01 · FY2016 · CA · contact PI
Imaging Core$179,244
P50 · FY2016 · CA · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$447,370
R01 · FY2015 · CA · contact PI
In vivo imaging of T Cells using engineered antibodies and PET$231,000
R21 · FY2015 · AI · contact PI
(PQC4) Imaging CD8 T Cells In Tumor Immunotherapy By Immunopet$200,970
R21 · FY2015 · CA · contact PI
Imaging Core$179,297
P50 · FY2015 · CA · contact PI
Cancer$20,837
P30 · FY2015 · ES · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$402,633
R01 · FY2014 · CA · contact PI
In vivo imaging of T Cells using engineered antibodies and PET$192,500
R21 · FY2014 · AI · contact PI
Imaging Core$179,156
P50 · FY2014 · CA · contact PI
(PQC4) Imaging CD8 T Cells In Tumor Immunotherapy By Immunopet$167,475
R21 · FY2014 · CA · contact PI
Cancer$20,789
P30 · FY2014 · ES · contact PI
Cancer$2,495
P30 · FY2014 · ES · contact PI
Multifunctional immunoPET tracers for pancreatic and prostate cancer$447,370
R01 · FY2013 · CA · contact PI
Imaging Core$177,600
P50 · FY2013 · CA · contact PI
Cancer Molecular Imaging$139,319
P30 · FY2013 · CA · contact PI
Cancer$20,371
P30 · FY2013 · ES · contact PI
Cancer Molecular Imaging$87,643
P30 · FY2012 · CA · contact PI
Cancer$37,216
P30 · FY2012 · ES · contact PI
Imaging Core$94,066
P50 · FY2011 · CA · contact PI
Cancer Molecular Imaging$45,130
P30 · FY2011 · CA · contact PI
Cancer$20,789
P30 · FY2011 · ES · contact PI
Biological Modification of Quantum Dots for in vivo Imaging$507,290
U54 · FY2010 · CA · contact PI
Imaging Core$99,016
P50 · FY2010 · CA · contact PI
Cancer Molecular Imaging$56,472
P30 · FY2010 · CA · contact PI
Biological Modification of Quantum Dots for in vivo Imaging$487,188
U54 · FY2009 · CA · contact PI
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene$257,253
P50 · FY2009 · CA · contact PI
Imaging Core$98,989
P50 · FY2009 · CA · contact PI
Cancer Molecular Imaging$53,525
P30 · FY2009 · CA · contact PI
Biological Modification of Quantum Dots for in vivo Imaging$459,429
U54 · FY2008 · CA · contact PI
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene$258,048
P50 · FY2008 · CA · contact PI
Imaging Core$98,984
P50 · FY2008 · CA · contact PI
Biological Modification of Quantum Dots for in vivo Imaging$450,238
U54 · FY2007 · CA · contact PI
Recombinant Carcinoembryonic Antigen as a PET Reporter Gene$258,098
P50 · FY2007 · CA · contact PI
Imaging Core$92,145
P50 · FY2007 · CA · contact PI
Biological Modification of Quantum Dots for in vivo Imaging$304,108
U54 · FY2006 · CA · contact PI
Recombinant Carcinoembronic Antigen as PET Reporter Gene$162,492
P50 · FY2006 · CA · contact PI
High-avidity multimeric cancer imaging agent$190,181
R21 · FY2005 · CA
Recombinant Carcinoembronic Antigen as PET Reporter Gene$162,492
P50 · FY2005 · CA
High-avidity multimeric cancer imaging agent$183,226
R21 · FY2004 · CA
BIOENGINEERED ANTIBODIES$0
P01 · FY2002 · CA
BIOENGINEERED ANTIBODIES$0
P01 · FY2001 · CA
BIOENGINEERED ANTIBODIES$156,497
P01 · FY2000 · CA